34 Recruiting Castration-Resistant Prostate Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Castration-Resistant Prostate Carcinoma
Related Conditions
Top Recruiting Castration-Resistant Prostate Carcinoma Studies
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
📍 City of Hope — Duarte, California
View Study & Checklist ➔Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
📍 Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
📍 Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas
View Study & Checklist ➔Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
📍 Rush University — Chicago, Illinois
View Study & Checklist ➔